JBS 3Q profit plunges 72% to $164M, US beef shows improvement
Published 1 d ago2 sourcesEvidence: Reported
Brazilian pharma Biomm posted a R$22.1 million net profit in Q3, reversing a prior-year loss, and reaffirmed confidence in hitting the lower end of its 2026 EBITDA guidance, possibly by November. The earnings beat is company-specific and not indicative of a broader sector trend. This is a routine earnings update with limited macro or geopolitical significance.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 1 d ago2 sourcesEvidence: Reported
Published 22 h ago2 sourcesEvidence: Reported
Published 21 h ago2 sourcesEvidence: Reported
Published 1 d ago4 sourcesEvidence: Reported
Published 12 h ago2 sourcesEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 2 d ago3 sourcesEvidence: Reported